CTLA4 and neoplasm: Furthermore, the impact of a combination of anti-CTLA-4 antibodies and therapeutic cancer vaccines has been identified as a promising combination therapy, altering the balance of regulatory T cells by increasing effector T cells in tumors with enhanced anti-tumor function.